SPECIAL

Immunotherapy for genitourinary cancers: where are we?

E. Seront, J.P. Machiels

The role of immunotherapy in non-metastatic non-small cell lung cancer

T. Feys

Immunotherapy in lung cancer: current approach and clinical application

D. Gullentops, E. Wauters, J. Vansteenkiste

Long-term survival in immunotherapy treated patients with unresectable advanced melanoma

B. Neyns, G. Awada, A. Rogiers

Indoleamine 2, 3-dioxygenase (IDO) inhibition for cancer therapy

L. Brochez, I. Chevolet, A. Meireson, V. Kruse